Literature DB >> 15246905

Comparison of once daily versus twice daily oral nitrates in stable angina pectoris.

Przemyslaw Kardas1.   

Abstract

This study aimed to compare patient compliance and treatment effectiveness in patients with stable angina pectoris who were treated with oral nitrates administered once daily versus twice daily. Using electronic measurement, significantly greater adherence to the once daily versus the twice daily nitrate regimen in terms of dosing and timing was found. Better effectiveness of the once daily formulation was also observed.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15246905     DOI： 10.1016/j.amjcard.2004.03.067

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  Medication adherence in heart failure.

Authors:  Paul J Hauptman
Journal:  Heart Fail Rev       Date:  2007-05-04       Impact factor: 4.214

2.  Noncompliance in the use of cardiovascular medications in the Medicare Part D population.

Authors:  Steven A Blackwell; David K Baugh; Melissa A Montgomery; Gary M Ciborowski; Charles J Waldron; Gerald F Riley
Journal:  Medicare Medicaid Res Rev       Date:  2011-12-14

3.  Self-reported versus 'true' adherence in heart failure patients: a study using the Medication Event Monitoring System.

Authors:  M M W Nieuwenhuis; T Jaarsma; D J van Veldhuisen; M H L van der Wal
Journal:  Neth Heart J       Date:  2012-08       Impact factor: 2.380

4.  Effectiveness and Impact on Adherence of a New Fixed-Dose Combination of Ivabradine and Metoprolol in a Wide Range of Stable Angina Patients in Real-Life Practice.

Authors:  Dimitar Divchev; Georg Stöckl
Journal:  Cardiol Ther       Date:  2019-08-13

Review 5.  Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis.

Authors:  Jenny Demonceau; Todd Ruppar; Paulus Kristanto; Dyfrig A Hughes; Emily Fargher; Przemyslaw Kardas; Sabina De Geest; Fabienne Dobbels; Pawel Lewek; John Urquhart; Bernard Vrijens
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

6.  Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.

Authors:  Przemyslaw Kardas
Journal:  Vasc Health Risk Manag       Date:  2007

7.  Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris.

Authors:  Yuri M Pozdnyakov
Journal:  Cardiol Ther       Date:  2018-05-19

Review 8.  Vasodilator Therapy: Nitrates and Nicorandil.

Authors:  Jason M Tarkin; Juan Carlos Kaski
Journal:  Cardiovasc Drugs Ther       Date:  2016-08       Impact factor: 3.727

9.  Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice.

Authors:  Maria G Glezer; Vladimir A Vygodin
Journal:  Adv Ther       Date:  2018-08-13       Impact factor: 3.845

10.  Effectiveness and Tolerability of Trimetazidine 80 Mg Once Daily in Patients with Stable Angina Uncontrolled with Bisoprolol-Based Therapy: The Modus Vivendi Observational Study.

Authors:  Yuri Lopatin; Parvoleta Petrova
Journal:  Cardiol Ther       Date:  2021-12-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.